CCND1 and colorectal carcinoma: There are no studies on the clinical significance of nEGFR expression in CRC, except for those referring to the breast, oropharyngeal squamous and ovarian cancer [14,24-26], with the expression associated with worse prognosis [12,24,25], increased proliferation and cyclin-D1 expression [25].